Zeshan Ahmed

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Simon Richardson

> Home > Persons > Zeshan Ahmed

Publications

2016
[j2]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - journals/neuroimage/ColganSOHWHIRAC16
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/neuroimage/ColganSOHWHIRAC16
Niall Colgan, Bernard Siow, James M. O'Callaghan, Ian F. Harrison, Jack A. Wells, Holly E. Holmes, Ozama Ismail, Simon Richardson, Daniel C. Alexander, Emily C. Collins, Elizabeth M. C. Fisher, Ross A. Johnson, Adam J. Schwarz, Zeshan Ahmed, Michael J. O'Neill, Tracey K. Murray, Hui Zhang, Mark F. Lythgoe:
Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease. NeuroImage 125: 739-744 (2016)
2015
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/neuroimage/WellsOHPJSTIWGR15
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/neuroimage/WellsOHPJSTIWGR15
Jack A. Wells, James M. O'Callaghan, Holly E. Holmes, Nick M. Powell, Ross A. Johnson, Bernard Siow, F. Torrealdea, Ozama Ismail, Simon Walker-Samuel, Xavier Golay, M. Rega, Simon Richardson, Marc Modat, Manuel Jorge Cardoso, Sébastien Ourselin, Adam J. Schwarz, Zeshan Ahmed, Tracey K. Murray, Michael J. O'Neill, Emily C. Collins, Niall Colgan, Mark F. Lythgoe:
In vivo imaging of tau pathology using multi-parametric quantitative MRI. NeuroImage 111: 369-378 (2015)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.